Quest Partners LLC trimmed its stake in Illumina, Inc. (NASDAQ:ILMN – Free Report) by 10.3% during the third quarter, ...

On Friday, Illumina Inc (ILMN) stock saw a modest uptick, ending the day at $140.14 which represents a slight increase of $3.15 or 2.30% from the prior close of $136.99. The stock opened at $137.77 ...

Genomic sequencing remains a relatively early stage market, and expanding sequencing indications, including the nascent liquid biopsy applications that would use its sequencers, create large growth ...

On Tuesday, Illumina Inc (ILMN) stock saw a modest uptick, ending the day at $135 which represents a slight increase of $4.26 or 3.26% from the prior close of $130.74. The stock opened at $130.11 and ...

Illumina, Inc. ILMN is expanding its TruSight Oncology portfolio with a new version of its flagship cancer research assay, currently under development. The TruSight Oncology 500 v2 (TSO 500 v2) to ...

We recently compiled a list of the 10 Best Immunotherapy Stocks to Buy Now. In this article, we are going to take a look at ...

Morgan Stanley reiterated their equal weight rating on shares of Illumina (NASDAQ:ILMN – Free Report) in a research note ...

We recently published a list of UBS’ Top Quant Stocks In AI, IT, Healthcare & Other Sectors: Top 33 Stocks In All Sectors. In ...

Utilizing one-week price change and the monthly percentage ... diagnostic and consumer genomics companies. ILMN is a Zacks Rank #3 (Hold) stock, with a Momentum Style Score of A and VGM Score ...

The data does tell us to set a stop loss 148.49 to protect against excessive loss in case the stock begins to move against the trade. 148.92 is the first level of support below 151.09, and by rule, ...

What is the Price to Earnings Growth (PEG) Ratio? The PEG Ratio chart for Illumina (ILMN) compares PE to EPS Growth rates. Defining fair value is the goal of measuring valuation using the PEG Ratio.